ATE359291T1 - Brustkrebsresistenzprotein (bcrp) und für dieses kodierende dna - Google Patents

Brustkrebsresistenzprotein (bcrp) und für dieses kodierende dna

Info

Publication number
ATE359291T1
ATE359291T1 AT99908097T AT99908097T ATE359291T1 AT E359291 T1 ATE359291 T1 AT E359291T1 AT 99908097 T AT99908097 T AT 99908097T AT 99908097 T AT99908097 T AT 99908097T AT E359291 T1 ATE359291 T1 AT E359291T1
Authority
AT
Austria
Prior art keywords
breast cancer
bcrp
dna coding
resistance protein
cancer resistance
Prior art date
Application number
AT99908097T
Other languages
English (en)
Inventor
Douglas D Ross
L Austin Doyle
Lynne Abruzzo
Original Assignee
Univ Maryland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22115664&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE359291(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Maryland filed Critical Univ Maryland
Application granted granted Critical
Publication of ATE359291T1 publication Critical patent/ATE359291T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/44—Multiple drug resistance

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Urology & Nephrology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT99908097T 1998-02-05 1999-02-05 Brustkrebsresistenzprotein (bcrp) und für dieses kodierende dna ATE359291T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7376398P 1998-02-05 1998-02-05

Publications (1)

Publication Number Publication Date
ATE359291T1 true ATE359291T1 (de) 2007-05-15

Family

ID=22115664

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99908097T ATE359291T1 (de) 1998-02-05 1999-02-05 Brustkrebsresistenzprotein (bcrp) und für dieses kodierende dna

Country Status (10)

Country Link
US (4) US6313277B1 (de)
EP (1) EP1054894B2 (de)
JP (1) JP4187412B2 (de)
AT (1) ATE359291T1 (de)
AU (1) AU755567B2 (de)
CA (1) CA2319715C (de)
DE (1) DE69935782T3 (de)
ES (1) ES2284243T5 (de)
IL (4) IL137466A0 (de)
WO (1) WO1999040110A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1054894B2 (de) * 1998-02-05 2016-11-09 University of Maryland Baltimore Brustkrebsresistenzprotein (bcrp) und für dieses kodierende dna
WO1999061589A2 (en) 1998-05-28 1999-12-02 St. Jude Children's Research Hospital Expansion of hematopoietic stem cells transduced with mdr-1 and methods of use thereof
US7622557B2 (en) * 1998-05-28 2009-11-24 St. Jude Children's Research Hospital Antibodies having binding specificity for the extracellular domain of a breast cancer resistance protein (BCRP)
AU1924000A (en) * 1998-11-30 2000-07-03 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The An atp-binding cassette protein responsible for cytotoxin resistance
US7138493B1 (en) * 1998-11-30 2006-11-21 The United States Of America As Represented By The Department Of Health And Human Services ATP-binding cassette protein responsible for cytotoxin resistance
ATE337016T1 (de) * 1999-05-17 2006-09-15 Cancer Res Ventures Ltd Zusammensetzungen zur erhöhung der bioverfügbarkeit von oral verabreichten pharmazeutischen verbindungen
AU2001288061A1 (en) * 2000-10-03 2002-04-15 Banyu Pharmaceutical Co., Ltd. Drug resistance-associated gene and use thereof
HU0100947D0 (en) * 2001-03-02 2001-05-28 Solvo Kft Screening system based on expression of abcg2 half transporter protein in an expression system free of other abc-transporters, abcg2 homodimers
US20050255084A1 (en) * 2001-10-24 2005-11-17 Solvo Biotechnology Use of a half-transporter protein of the abcg-family for selecting cells and in gene therapy
US20060135445A1 (en) * 2003-02-04 2006-06-22 Kabushiki Kaisha Yakult Honsha Breast cancer-resistant protein inhibitor
JP2006069910A (ja) * 2004-08-31 2006-03-16 Yoshiichi Sugimoto 抗癌剤耐性克服剤
EP1672365A1 (de) * 2004-12-16 2006-06-21 Het Nederlands Kanker Instituut Mittel und Verfahren zur Bestimmung und Beeinflussung des zellulären Transports
US7465788B2 (en) * 2005-01-18 2008-12-16 University Of Maryland Breast cancer resistance protein (BCRP) and antibodies thereto
KR102113239B1 (ko) 2012-09-11 2020-05-21 코닝 인코포레이티드 약물 트랜스포터 단백질(들) 및/또는 약물대사 효소(들)를 인코딩하는 유전자(들)를 일시적으로 과발현하는 소모성 냉동보존 세포
KR101561965B1 (ko) 2013-11-27 2015-10-20 한국과학기술연구원 디스코이딘 도메인 수용체 2 활성을 조절하는 물질의 동정 방법
US20220256794A1 (en) * 2019-05-08 2022-08-18 The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization Terpene synthases and transporters

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5585479A (en) * 1992-07-24 1996-12-17 The United States Of America As Represented By The Secretary Of The Navy Antisense oligonucleotides directed against human ELAM-I RNA
US5489519A (en) * 1992-10-27 1996-02-06 Queen's University At Kingston Multidrug resistance protein
EP0975795A1 (de) * 1997-02-24 2000-02-02 TM Technologies Inc. Verfahren zur selektion von anti-strang-oligonukleotiden
WO1998055614A2 (en) * 1997-06-04 1998-12-10 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
US7122373B1 (en) * 1998-05-14 2006-10-17 Nuvelo, Inc. Human genes and gene expression products V
EP1054894B2 (de) * 1998-02-05 2016-11-09 University of Maryland Baltimore Brustkrebsresistenzprotein (bcrp) und für dieses kodierende dna
WO2000018912A2 (en) * 1998-09-25 2000-04-06 Bayer Aktiengesellschaft Atp binding cassette genes and proteins for diagnosis and treatment of lipid disorders and inflammatory diseases
AU1924000A (en) * 1998-11-30 2000-07-03 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The An atp-binding cassette protein responsible for cytotoxin resistance
AU2001288061A1 (en) 2000-10-03 2002-04-15 Banyu Pharmaceutical Co., Ltd. Drug resistance-associated gene and use thereof
AU2003238704A1 (en) 2002-06-17 2003-12-31 Banyu Pharmaceutical Co., Ltd. Method for predicting a drug transport capability by abcg2 polymorphisms

Also Published As

Publication number Publication date
US20090104199A1 (en) 2009-04-23
EP1054894B1 (de) 2007-04-11
WO1999040110A1 (en) 1999-08-12
ES2284243T3 (es) 2007-11-01
IL177612A (en) 2011-04-28
US7741445B2 (en) 2010-06-22
IL137466A (en) 2011-04-28
DE69935782T2 (de) 2007-08-16
US7655755B2 (en) 2010-02-02
JP2002502592A (ja) 2002-01-29
US20050272684A1 (en) 2005-12-08
IL191982A (en) 2011-09-27
IL137466A0 (en) 2001-07-24
EP1054894A1 (de) 2000-11-29
EP1054894B2 (de) 2016-11-09
US20030036645A1 (en) 2003-02-20
US6313277B1 (en) 2001-11-06
US7541437B2 (en) 2009-06-02
JP4187412B2 (ja) 2008-11-26
IL191982A0 (en) 2008-12-29
ES2284243T5 (es) 2017-08-22
AU755567B2 (en) 2002-12-12
CA2319715C (en) 2012-08-07
CA2319715A1 (en) 1999-08-12
DE69935782T3 (de) 2017-01-05
EP1054894A4 (de) 2002-03-13
AU2761099A (en) 1999-08-23
DE69935782D1 (de) 2007-05-24

Similar Documents

Publication Publication Date Title
IL191982A0 (en) Breast cancer resistance protein (bcrp) and the dna which encodes it
EA199700447A1 (ru) Последовательность днк и кодируемый ею специфический для молочной железы белок карциномы молочной железы
CY1112101T1 (el) Νευροτροφικοι παραγοντες
DE69939982D1 (de) B7l-1 moleküle
DE69841110D1 (de) Verlängerte cdns, die für sekretierte proteine kodieren
DE60227974D1 (de) Diagnostische tests auf periostinbasis
IL193886A0 (en) Antibodies that bind to ldcam sequences
ATE365210T1 (de) Glykosylierte proteine mit reduzierter allergenität
EE9800306A (et) Isoleeritud dimeerne fibroblastide aktivatsioonivalk alfa ja selle kasutusalad
MXPA03008110A (es) Mutantes de interleucina-18, su produccion y uso.
WO2002088750A3 (en) Proteins, genes and their use for diagnosis and treatment of breast cancer
ATE473279T1 (de) In metastatischen menschlichen tumorzellen exprimiertes glycoproteinantigen sima135
AU3392901A (en) Proteins
ES2192199T3 (es) Ligandos de la familia eph biologicamente activos.
SG165168A1 (en) New adenoviruses, nucleic acids coding therefor and their use
GB0004576D0 (en) Proteins
ATE368733T1 (de) Bfit (brown fat inducible thioesterase) polypeptide und polynukleotide und ihre verwendung
CY1109904T1 (el) Προαγωγεας της il-18bp, η παρασκευη και χρηση του
DE69930370D1 (de) Testisspezifische, menschliche proteinase, svph1-8
ATE408687T1 (de) Semaphorin polypeptide
WO2001055209A3 (en) Novel human septin and uses thereof
DK0858465T3 (da) Protein med antitumorvirkning.
DE69739223D1 (de) Oden und anwendungen
SE0003099D0 (sv) Adhesive protein and uses therefore
AU4956901A (en) Novel human 7tm proteins and polynucleotides encoding the same

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties